THE development of the search for endogenic carcinogens has been reported in earher publications from this Institute, (see Hieger (1949) for references to previous papers). It has been shown that the cholesterol-rich fraction of'tissues from human subjects who had died of cancer or of other causes, and even commercial cholesterol. is a carcinogen. The present paper deals with the evidence for the careinogemc activity of; the purified sterol itself.
It will be useful to first present in greater detail the data for the results obtained with commercial cholesterol before it has undergone any special purification, i.e., as bought. Table I and Summary to Table I show the survival rate and-tumour incidence in the first series of tests. Table I have been reported in the 1949 paper (Hieger, 1949, p. 132, section 10d). They are repeated here especially to show that when this particular series of test was extended (it was carried on over the period [1944] [1945] [1946] [1947] [1948] [1949] to further groups of mice, and, moreover, with different samples of commercial cholesterol, the activity of the sterol remained within the hmits of uncertainty characteristic of the tests with this substance, provided other conditions remain unaltered. AR " tumours " in this paper are sarcomas at the site of injection, usually of spindle ceR type. Photomicrographs are show-n in the plates (Fig. I to 6 ). A good proportion of these sarcomas transplanted well. The first tumour in Table I was carried through 93 generations and the first tumour in Table IV (highly purified cholesterol) has been growing vigorously in its 25th generation. The latent period is in the neighbourhood of 19 months (Table IX) . The technique of assay has been to inject 0-1-0-4 c.c. of a 10 or 15 per cent solution of the sterol subcutaneously into mice as often as is required to maintain a nodule under the skin. On the average, each mouse received of the order of 3 to 5 injections during the course of the test which lasted from the time the m-ice were 6-1 0 weeks of age until their death. In the earher tests lard, supplied.by a-single firm, was used as the solvent, but in 1950 it was found that a large batch of lard from the same source had different physical properties from the lard supplied until then, and it was decided to change to olive ofl as solvent, although that alteration did not guarantee that there would result a greater uniformity in the composition of the solvent at future times. It would have been advantageous from some points of view to have chosen a synthetic solvent such as tricaprylin, but since a naturally occurring fat, i.e., lard, had already been in use for a considerable time the change to another naturally occurring fat, olive oil, was considered not to be as drastic a change in techn'ique as would changing to a synthetic solvent. The control tests on solvents are described further on in this paper.
Some of the experiments in
Purification of the cholesterol was next undertaken, as a first step using the simplest technique. The results of the mouse tests on this purified cholesterol are show-n in Table IV . This experiment was carried out at our Buckinghamshire laboratories in the Hydrocarbon-Carcinogen free laboratory "; the mice were housed in the same room as the control series (Table V) 3  3  3  3  2  2  1  1  0  0  5  4  2  0  0  3  2  2  2  2  1  1  1  0  0  3  3  2  2  1  1  0  0  3  3  2  2  0  0  4  3  3  3  2  2  0  0  3  3  3  2  2  2  0  0  4  3  3 (Table VI) .
To assess the carcinogenic activity of a material by a number denoting the ratio (as a percentage) of tumour bea-ring mice to the total number of mice treated cannot be satisfactory, for obviously the mice whic'h die before the average expected latent period cannot have had adequate exposure to the carcinogen. It would be an improvement if the assay were calculated as the percentage of tumours induced in the mice which survive to the average latent period or at least to the minimum latent period.
The data obtained from the experiments carried out with purified sterol at the Chester Beatty Institute (Table III) do not support the contention that .h,.
carcinogenesis is due to the sterol, but it should be observed that some -disturb factors appeared in this test. The mice did not survive well, and in fact the single sarcoma appeared at the 27th month in the sole survivor of the 34 mice initioy injected with purified cholesterol. Twenty-seven months is near the outsidei limit of the range of latent periods found with the carcinogens of the cholesterol categpyy,, In an experiment with commercial cholesterol (Table II, (Fig. 8) .
Curve The low absorption shown by Curve 2 (low, that is, compared with the curve for the commercial product) and its inactivity, carcmogenically, suggests that treatment bv crystalhsing from acetone removes the active fraction. However, it is difficult to explain why Fractions a and e, which contained all the subsequent fractions, including i, did not induce tumours. When this process (crystallising from acetone) was apphed on a larger scale (Table 11) to commercial cholesterol it was found that the active fraction was concentrated in the crystalline product which was much more active than the mother liquors, and here the absorption curve of the acetone crystal fraction (Ctirve 5) showed considerably less absorption than did the cholesterol before treatment (Curve I 1). Moreover (Table III) . The tests with the commercial sample were done on stock mice and one.,7 mice; with the pure sample they were done onC57mice, on the expectation that if pure and commercial cholesterol and the control (ohve off) series were tested on the same pure hne strain of mouse, more consistency would be attained. (Table I) it should be noted that:
(1) These tests, (Table V) were conducted in a hydrocarbon-carcinogen free room. When the test was conducted in a room where the atmosphere might be contaminated with hydrocarbon-carcinogen vapour, the incidence of tumours was about as Iiigh as the incidence found at the Chester Beatty laboratory.
(2) A first-step purification by simple acetone crystalHsation of commercial cholesterol was sufficient to appreciably decrease the absorption without affecting the carcinogenic activity.
In the Chester Beatty tests (Tables I, II 
APPENDIX.
INFRA-RED SPECTRA. The purity of the cholesterol fractions has been further followed by infra-red spectral measurements. Attention was directed to the spectra in the region characteristic of double-bond absorption, namely at 1650-1750 cm.-'. In this region, cholesterol itself has only the one weak band at 1665 cm.-' due to its single ethylenic double-bond, so that the presence of carbonyl containing impurities should be easily detected due to the relatively high intensity of absorption of such groups.
From a study of the exact frequency of this band in a large number of carbonylcontaining steroids, it has been shown (Jones, Humphries and Dobriner, 1950) that a strict correlation occurs, so that from the frequency of the band, the position of the carbonyl group in the molecule can be deduced. Furthermore, it has been bhown (Jones, Ramsay, Keir and Dobriner, 1952) that the intensity of absorption per carbonyl group is constant for each particular type and is independant of the rest of the molecule. From the carbonyl absorption found in cholesterol fractions, therefore, the type of impurity and its approximate amount can be deduced.
Cholesterol preparation numbers, 3, 4, 6, 7 and 9 (for key, vide supra) showed no appreciable carbonyl absorption (less than 0-25 per cent). Number 8 (Glaxo sample 5989) had a band at 1744 cm.-', assigned to a 17-ketone, equivalent to about 1 per cent of such an impurity. Number 11 (Glaxo sample 1201) had three bands at 1744, 1710 and 1674 cm-'; these indicate about 9 per cent of a 17-ketone, 4 per cent of a 20-ketone (or possibly in a 6-membered ring) and 3 per cent of an ac, unsaturated ketone, probably a A4: 3-ketone. Number 5, which was the least soluble fraction obtained by fractional crystallisation of this latter commer-cial sample had the same bands but reduced in intensity to about 3 of the original, indicating a considerable purification of the cholesterol. The most soluble fraction in this crystallisation and used for the test in Section D, Table II (number 13) contained the impurities concentrated about five-fold. The progress of this purification procedure can be followed in Fig. 7 , which shows the relevant spectra.
By comparison with the findings from the ultra-violet spectra, absorption at 235 m, appears to correspond to carbonyl absorption in the infra-red, but absorption at 251m,u, as in number 4, does not correspond to such absorption in the infra-red; the main impurity in 4 must therefore be of non-carbonyl origin.
All infra-red spectra were measured in CS2 solution in 1 to 3 mm. cells on a Perkin Elmer 12C spectrometer. 
